Statin, Ezetimibe, or Fibrate Initiation and Subsequent Use for the Primary and Secondary Prevention of Cardiovascular Diseases among Japanese Patients Aged ≥55 Years: A Nationwide Cohort Study
Biological and Pharmaceutical Bulletin · 2023
DOI: 10.1248/bpb.b23-00336 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Biological and Pharmaceutical Bulletin, 2023. Verfasst von Junko Tomida und 5 weiteren Autor:innen. Beteiligte Einrichtung: Kagawa School of Pharmaceutical Sciences, Tokushima Bunri University. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Dyslipidemias, Hydroxymethylglutaryl-CoA Reductase Inhibitors. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 38 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Kagawa School of Pharmaceutical Sciences, Tokushima Bunri University.
- Faculty of Pharmaceutical Sciences, Tokyo University of Science.
- Faculty of Health and Welfare, Tokushima Bunri University.
Zitieren
APA
Tomida, J., Sato, T., Yoshida, T., Senda, S., Nakatsuma, A., & Iihara, N. (2023). Statin, Ezetimibe, or Fibrate Initiation and Subsequent Use for the Primary and Secondary Prevention of Cardiovascular Diseases among Japanese Patients Aged ≥55 Years: A Nationwide Cohort Study. Biological and Pharmaceutical Bulletin. https://doi.org/10.1248/bpb.b23-00336
Vancouver
Tomida J, Sato T, Yoshida T, Senda S, Nakatsuma A, Iihara N. Statin, Ezetimibe, or Fibrate Initiation and Subsequent Use for the Primary and Secondary Prevention of Cardiovascular Diseases among Japanese Patients Aged ≥55 Years: A Nationwide Cohort Study. Biological and Pharmaceutical Bulletin. 2023. doi:10.1248/bpb.b23-00336
BibTeX
@article{Tomida2023,
author = {Tomida, Junko and Sato, Tsugumichi and Yoshida, Tomoji and Senda, Shoichi and Nakatsuma, Akira and Iihara, Naomi},
title = {Statin, Ezetimibe, or Fibrate Initiation and Subsequent Use for the Primary and Secondary Prevention of Cardiovascular Diseases among Japanese Patients Aged ≥55 Years: A Nationwide Cohort Study},
journal = {Biological and Pharmaceutical Bulletin},
year = {2023},
doi = {10.1248/bpb.b23-00336}
}
EUVIMED